biopharmaceuticals | chemanager-online.com - Chemistry and Life Science

Nov. 21, 2019
News & Opinions
Rentschler Kicks off Expansion at US Facility
Laupheim, Germany-based contract development and manufacturing organization (CDMO) for biopharmaceuticals, Rentschler Biopharma, is taking the first step in the expansion project to grow its US footprint. The CDMO will establish a Center ...
Oct. 29, 2019
Topics
Driving Innovation and Extending Its Global Reach
Last year, Rentschler Biopharma, a German contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced its "Strategy 2025." As an important part of this strategy, the company plans to offer new ...
Oct. 09, 2019
News & Opinions
Rentschler Biopharma Extends Japanese Pact
German biopharmaceuticals contract development and manufacturing organization Rentschler Biopharma is extending and deepening its existing collaboration in Japan with Summit Pharmaceuticals International (SPI), a wholly owned subsidiary of ...
Sep. 25, 2018
News & Opinions
Boehringer Ingelheim Buys ViraTherapeutics
Boehringer Ingelheim has taken an option to buy all the shares of ViraTherapeutics, an Austrian biopharma that specializes in developing immunotherapy drugs based on oncolytic viruses. ...
Dec. 02, 2017
Topics
Ireland’s Thriving Pharma and Chemicals Producers Optimistic about Brexit
Of the remaining post-Brexit 27 member states of the European Union, Ireland looks likely to suffer the most economically, and also possibly politically, as a result of the UK’s withdrawal from the EU in March, 2019.
Jun. 13, 2017
News & Opinions
J&J Expects Actelion Deal to Close This Week
The European Commission has approved plans by US healthcare group Johnson & Johnson to acquire Swiss biotech Actelion, thus completing all global regulatory approvals. J&J said it now expects the all-cash public tender offer ...
Mar. 15, 2017
News & Opinions
Roquette to Launch New Biopharmaceutical Brands
French family-owned group Roquette plans to introduce three new brands to address the growing demand for excipients and raw materials for the biopharmaceutical market. ...
Mar. 15, 2016
News & Opinions
Patheon and Amgen in Toll Manufacturing Pact
US contract drug development and manufacturing services provider Patheon has signed a toll production agreement with leading biotechnology company Amgen. The US firms are based at Durham, North Carolina, and Thousand Oaks, California, ...
Jan. 15, 2016
News & Opinions
Lonza Expands UK Mammalian Production
Swiss fine and specialty chemicals producer Lonza has expanded its mammalian production capacity to meet increased demand for biopharmaceutical development and clinical manufacturing services. ...
Jan. 12, 2016
News & Opinions
Shire to Acquire Baxalta for $32 Billion
In a deal worth around $32 billion, Irish drug maker Shire – headquartered in Dublin but managed from Boston, Massachusetts – has agreed a takeover of US biopharmaceutical company Baxalta, spun off last year from Baxter ...

12 3 4 5 6

Register now!

The latest information directly via newsletter.

GIT Verlag